EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische Studie

Minimal Clinically Important Difference for the PeLTQL in Pediatric Liver Transplantation: A Multicenter Analysis

Vicky L Ng iD, Karina Kwan, Sherrie Logan, Julie Chessell, Steven J Lobritto iD, Evelyn K Hsu, Emily R Perito iD, Nitika A Gupta, Claire Dunphy, Daniel Pieratt, Lawrence C Kleinman, Eyal Shemesh und 1 weitere

Pediatric Transplantation · 2026-04 · 30 (4)

DOI: 10.1111/petr.70320 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Pediatric Transplantation, online erschienen am 20.04.2026. Verfasst von Vicky L Ng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Liver Transplantation, Minimal Clinically Important Difference, Patient Reported Outcome Measures, Quality of Life. Die Arbeit nennt 29 Literaturangaben. Gefördert von: The Agency for Healthcare Research and Quality, AHRQ HHS, Agency for Healthcare Research and Quality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patient‐reported outcomes are increasingly recognized as essential complements to biological indices in chronic disease including pediatric liver transplantation. However, clinicians lack clear thresholds to determine when changes in patient‐reported outcome measure (PROM) scores represent clinically meaningful change. Establishing minimal clinically important difference (MCID) values is critical to interpret longitudinal PROM data and guide action. The Starzl Network Patient Reported Outcomes (SPaRO) study provided a unique opportunity to derive MCID estimates of the Pediatric Liver Transplant Quality of Life (PeLTQL) questionnaire.

Methods

In SPaRO, English‐ or Spanish‐speaking pediatric LT recipients aged 8–18 years and at least 1 year post‐LT were recruited from 7 Starzl Network for Excellence in Pediatric Transplantation (SNEPT) sites. Participants and caregivers completed the PeLTQL (self‐ and proxy‐report) questionnaire twice via a mobile application or web‐based platform. MCIDs were estimated using anchor‐based and distribution‐based methods including predictive modeling.

Results

A total of 98 patients and 86 caregivers completed two PeLTQL assessments between March 2022 and October 2023. Triangulated MCID values for the total score (TS) were 6.4 (self‐report) and 5.6 (proxy‐report). Predictive modeling yielded estimates of 7.7 (self) and 6.8 (proxy).

Conclusions

In this multicenter cohort, MCID thresholds for the PeLTQL TS were approximately 6–8 points (self‐report) and 6–7 points (proxy‐report), consistent with prior single‐center estimates. Changes in the PeLTQL TS of greater than 6 points may help clinicians identify patients who warrant closer attention. Prospective validation using an independent anchor is underway. Trial Registration ClinicalTrials.gov Identifier: NCT05241847

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationMinimal Clinically Important DifferencePatient Reported Outcome MeasuresQuality of LifeAdolescentChildFemaleHumansMaleSurveys and Questionnaires

Stichwörter der Autor:innen

HRQOLlong‐term outcomesmetricsquestionnairessurvivorship

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Patient and Family Voice, Starzl Network for Excellence in Pediatric Transplantation, Pittsburgh, Pennsylvania, USA.
  • Morgan Stanley Children's Hospital of New York, Columbia University Medical Center, New York, New York, USA.
  • Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington, USA.
  • UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, California, USA.
  • Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Vicky L Ng, Steven J Lobritto, Emily R Perito, George V Mazariegos

Förderung

  • The Agency for Healthcare Research and Quality
  • AHRQ HHS
  • Agency for Healthcare Research and Quality

Zitieren

APA

Ng, V. L., Kwan, K., Logan, S., Chessell, J., Lobritto, S. J., Hsu, E. K., Perito, E. R., Gupta, N. A., Dunphy, C., Pieratt, D., Kleinman, L. C., Shemesh, E., & Mazariegos, G. V. (2026). Minimal Clinically Important Difference for the PeLTQL in Pediatric Liver Transplantation: A Multicenter Analysis. Pediatric Transplantation, 30(4). https://doi.org/10.1111/petr.70320

Vancouver

Ng VL, Kwan K, Logan S, Chessell J, Lobritto SJ, Hsu EK, et al. Minimal Clinically Important Difference for the PeLTQL in Pediatric Liver Transplantation: A Multicenter Analysis. Pediatric Transplantation. 2026;30(4). doi:10.1111/petr.70320

BibTeX
@article{Ng2026,
  author = {Ng, Vicky L and Kwan, Karina and Logan, Sherrie and Chessell, Julie and Lobritto, Steven J and Hsu, Evelyn K and Perito, Emily R and Gupta, Nitika A and Dunphy, Claire and Pieratt, Daniel and Kleinman, Lawrence C and Shemesh, Eyal and Mazariegos, George V},
  title = {Minimal Clinically Important Difference for the PeLTQL in Pediatric Liver Transplantation: A Multicenter Analysis},
  journal = {Pediatric Transplantation},
  year = {2026},
  volume = {30},
  number = {4},
  doi = {10.1111/petr.70320}
}
Kostenlos starten →